As of 2026-09-19, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.7x | 15.9x |
| Forward P/E multiples | 17.2x - 29.0x | 18.6x |
| Fair Price | (79.51) - (77.33) | (79.72) |
| Upside | -216.1% - -212.9% | -216.4% |
| Date | EV/EBITDA |